Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Vet Ophthalmol. 2014 Jul 15;18(3):242–250. doi: 10.1111/vop.12194

Figure 8.

Figure 8

Quantitative real-time PCR results demonstrating the relative expression of αSMA mRNA. TGFβ1 treatment (1ng/ml) induced significant αSMA formation (four-fold) in myofibroblasts and 200 μg/ml PFD treatment significantly decreased TGFβ1-induced myofibroblast formation. Error bars indicate standard error.

* denotes P < 0.001 (untreated control versus TGFβ1 treatment)

** denotes P < 0.001 (TGFβ1 treatment versus TGFβ1 + PFD treatment).